Connect with us


Chris Christie says he won’t rule out running against Trump in 2024



chris christie

Former New Jersey Gov. Chris Christie is considering another run for president in 2024, despite rumors that President Donald Trump will also run in 2024.

In an interview on Monday with talk show host Hugh Hewitt, Christie said, “I would not rule it out,” when asked if he would run for president – even against Trump.

Christie ran for the 2016 Republican presidential nomination before suspending his campaign and endorsing Trump.

Christie has since become an ally to President Trump, serving as the head of the president’s 2016 transition planning team. He also was involved in Trump’s debate Trump against President-elect Joe Biden.

In Monday’s interview, the former New Jersey governor said he does not agree with how Trump is handling his loss to President-elect Joe Biden.

“The president is very, very focused now just on his continued concerns about how the election went, those are things that he and I do not agree on. I try not to agitate him too much. I’ve been his friend for 20 years, I’ll continue to be his friend but on this one, we have a fundamental disagreement,” Christie said.

Christie told Hewitt that he was doubtful Trump would attend Biden’s inauguration on Jan. 20.

“I think he should. I think these type of rituals and traditions and norms are important in our democracy, but I’m doubtful that he will,” Christie said. “But he’s Donald Trump, which makes him very unpredictable so you never quite know.”

Christie noted that he was upset by President Trump’s loss to Biden.

“I was very disappointed that he lost,” Christie said. “Losing in politics hurts much more than winning feels good.”

When asked by Hewitt if Christie had a Christie 2024 URL reserved, he replied, “ is [reserved], so we’re going to keep that one, and we’ll see where we go from here.”

You may like

Continue Reading


Elizabeth Warren Acknowledges Unintended Consequences of Obamacare



Elizabeth Warren

Senator Elizabeth Warren of Massachusetts, a longtime supporter of the Affordable Care Act, commonly known as Obamacare, is now acknowledging the unintended consequences of the healthcare legislation, particularly its impact on industry consolidation and rising healthcare prices.

Warren, who has been a vocal proponent of Obamacare, has recently had what the Wall Street Journal reported as an “epiphany” regarding the consequences of the healthcare law. In a letter addressed to the Health and Human Services Department inspector general, Warren, along with Senator Mike Braun of Indiana, expressed concerns about vertically-integrated healthcare companies potentially increasing prescription drug costs and evading federal regulations.

According to reports from Fox News, the bipartisan letter highlighted issues with the nation’s largest health insurers allegedly bypassing Obamacare’s medical loss ratio (MLR). According to Warren, these insurers, through vertical integration, have manipulated the system, leading to “sky-high prescription drug costs and excessive corporate profits.”

The senators detailed how conglomerates, like UnitedHealth Group, with ownership across various healthcare sectors, could inflate medical payments to pharmacies and, by realizing those payments on the pharmacy side, appear to comply with MLR requirements while retaining more profits.

Moreover, despite the Democrats’ argument that the MLR would benefit patients, it has incentivized insurers to merge with or acquire pharmacy benefit managers (PBMs), retail and specialty pharmacies, and healthcare providers. This, in turn, has made healthcare spending less transparent, as insurers can allegedly shift profits to their affiliates by increasing reimbursements.

Warren, who has consistently voted against Obamacare repeal efforts, notably advocated for a “Medicare for All” proposal during her 2020 presidential campaign. Despite her prior support for the healthcare law, Warren’s recent concerns about its unintended consequences have raised questions about the long-term effects of Obamacare and its impact on the healthcare industry.

You may like

Continue Reading